We are live on ! Find out more
OTIC

Otonomy, Inc.

Delisted

OTIC was delisted on the 22nd of December, 2022.

47 hedge funds and large institutions have $68.1M invested in Otonomy, Inc. in 2019 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 15 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more capital invested

Capital invested by funds: $38.9M → $68.1M (+$29.2M)

50% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 6

7% more funds holding

Funds holding: 4447 (+3)

60% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 15

Holders
47
Holders Change
+3
Holders Change %
+6.82%
% of All Funds
0.92%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
9
Increased
6
Reduced
15
Closed
6
Calls
$114K
Puts
Net Calls
+$114K
Net Calls Change
+$103K

OTIC Hedge Fund Activity: Q4 2019 in Review

47 of the 5,092 institutional investors tracked by Wall St. Rank reported a position in Otonomy, Inc. (OTIC) for Q4 2019, worth a combined $68.1M — up 75% from $38.9M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new OTIC positions and 6 closed out — a net gain of 3 holders — while 6 added to existing stakes and 15 trimmed.

The largest buyer was DAFNA Capital Management, opening a new position worth an estimated $1.15M. The largest seller was First Manhattan, cutting an estimated $3.08M.

  • 47 institutional investors held Otonomy, Inc. (OTIC) as of Q4 2019, up from 44 in Q3 2019.
  • Funds reported $68.1M of Otonomy, Inc. stock for Q4 2019, up 75% quarter-over-quarter.
  • 9 funds opened new Otonomy, Inc. positions in Q4 2019 and 6 closed out, a net change of +3 holders.
  • The largest Otonomy, Inc. buyer in Q4 2019 was DAFNA Capital Management, an estimated $1.15M added.
  • The largest Otonomy, Inc. seller in Q4 2019 was First Manhattan, an estimated $3.08M sold.

Based on aggregated 13F filings for Q4 2019.